Article Details
Retrieved on: 2021-08-27 00:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Inc. ("Bolt") (Nasdaq: BOLT), a clinical-stage biotechnology company ... targeting with the power of innate and adaptive immune system response.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here